- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stereotaxis Inc (STXS)
The Stereotaxis share price today is 1.900, view NYSE STXS stock exchange data. Track the latest Stereotaxis share price with real-time updates on STXS stock performance including market cap, day range, 52-week range and dividend yield. Access STXS charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.815
1.910
52 wk Range
1.700
3.590
STXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8151.910
52 wk Range
1.7003.590
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STXS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
4.125
Upside
+117.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
- Form 8K Stereotaxis Inc For: 15 April
- Investing.com
- Form 8K Stereotaxis Inc For: 15 May
- Investing.com
- Stereotaxis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form 8K Stereotaxis Inc For: 15 May
- Investing.com
- Stereotaxis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.125
(+117.11% Upside)
Stereotaxis Inc Earnings Call Summary for Q1/2026
- Stereotaxis Q1 2026 revenue fell 27.87% below forecast to $6.3M; EPS of -$0.06 missed estimates by 20%, triggering 3.72% stock decline to $1.81.
- Total revenue dropped 15.9% YoY due to strategic shift from Johnson & Johnson catheters to proprietary MAGiC catheter, temporarily impacting recurring revenue.
- Operating loss widened to $6.0M from $5.9M YoY; gross margin held at 60% despite production constraints limiting new product revenue realization.
- Company targets 500 catheters/month production by end-2026; new MAGiC catheter and Synchrony Digital Surgery Cockpit expected to drive future growth.
- Stock trades near 52-week low of $1.74, down 18% YTD; analysts maintain $4-$5 price targets, suggesting potential 100%+ upside despite near-term challenges.
Last Updated: 13-05-2026, 02:56 am
Read Full TranscriptEarnings
Latest Release
12-05-2026
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
6.29M / 8.72M
Compare STXS to Peers and Sector
Metrics to compare | STXS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTXSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.9x | −3.7x | −0.5x | |
PEG Ratio | −0.38 | −0.23 | 0.00 | |
Price/Book | 12.6x | 4.5x | 2.6x | |
Price / LTM Sales | 5.8x | 2.9x | 3.1x | |
Upside (Analyst Target) | 116.2% | 48.7% | 54.0% | |
Fair Value Upside | Unlock | 13.6% | 6.5% | Unlock |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Stereotaxis (STXS) Share Price Today?
The Stereotaxis share price today is 1.900.
What is the current Stereotaxis (STXS) share price and day range?
As of 21-05-2026, the Stereotaxis share price is 1.900, with a previous close of 1.850. The share price has ranged from 1.815 to 1.910 today, while the 52-week range spans from 1.700 to 3.590.
What Is the Stereotaxis Market Cap?
As of today, Stereotaxis market cap is 185.700M.
What Is the Stereotaxis (STXS) Share Price Target?
The average 12-month share price target for Stereotaxis is 4.125, with a high estimate of 5 and a low estimate of 3.5. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +117.11% Upside potential.
What Is Stereotaxis's Earnings Per Share (TTM)?
The Stereotaxis EPS (TTM) is -0.245.
When Is the Next Stereotaxis Earnings Date?
Stereotaxis will release its next earnings report on 11-08-2026.
From a Technical Analysis Perspective, Is STXS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Stereotaxis Trade On?
Stereotaxis is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Stereotaxis?
The stock symbol for Stereotaxis is "STXS."
How Many Times Has Stereotaxis Stock Split?
Stereotaxis has split 2 times.
How Many Employees Does Stereotaxis Have?
Stereotaxis has 131 employees.
What Is the STXS Premarket Price?
STXS's last pre-market stock price is 1.866. The pre-market share volume is 450.000, and the stock has changed by 0.016, or 0.860%.
What Is the STXS After Hours Price?
STXS's last after hours stock price is 1.928, the stock has changed by 0.028, or 1.490%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.